Literature DB >> 6324177

Vitamin D metabolites change the phenotype of monoblastic U937 cells.

R C Dodd, M S Cohen, S L Newman, T K Gray.   

Abstract

U937 is a human-derived lymphoma cell line that has monoblastic properties and high-affinity receptors for 1 alpha,-dihydroxyvitamin D3. Incubation of these cells with the vitamin D metabolite at 10 nM for 5 days produced marked stimulation in adherence and ingestion of Staphylococcus aureus (645% of control) and of C3b receptor (CR1) expression (292% of control) and a slight increase in hexose monophosphate shunt activity without changing cell growth rates or Fc fragment receptor expression. The changes in cellular association of S. aureus and the CR1 were detected as early as 48 hr of incubation and peaked between 3 and 5 days. Similar changes in the CR1 were induced by 25-hydroxy- and 24,25-dihydroxyvitamin D3 at micromolar concentrations. Dexamethasone, hydrocortisone, and progesterone had no effect on CR1 expression. U937 cells incubated in the presence of vitamin D metabolites exhibited a change in their phenotype. These results suggest that vitamin D metabolites may contribute to monocyte/macrophage differentiation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6324177      PMCID: PMC389987          DOI: 10.1073/pnas.80.24.7538

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane.

Authors:  D T Fearon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

2.  Fc receptor heterogeneity: immunofluorescent studies of B, T, and "third population" lymphocytes in human blood with rabbit IgG b4/anti-b4 complexes.

Authors:  J B Winfield; P I Lobo; M E Hamilton
Journal:  J Immunol       Date:  1977-11       Impact factor: 5.422

3.  In vitro activation of a human macrophage-like cell line.

Authors:  H S Koren; S J Anderson; J W Larrick
Journal:  Nature       Date:  1979-05-24       Impact factor: 49.962

4.  1 Alpha,25-dihydroxycholecalciferol receptors in intestine. II. Temperature-dependent transfer of the hormone to chromatin via a specific cytosol receptor.

Authors:  P F Brumbaugh; M R Haussler
Journal:  J Biol Chem       Date:  1974-02-25       Impact factor: 5.157

5.  Surface glycoproteins of human non-T, non-B acute lymphocytic leukemia cell lines.

Authors:  C G Gahmberg; L C Andersson; K Nilsson
Journal:  Leuk Res       Date:  1980       Impact factor: 3.156

6.  Characterization of a human macrophage-like cell line stimulated in vitro: a model of macrophage functions.

Authors:  J W Larrick; D G Fischer; S J Anderson; H S Koren
Journal:  J Immunol       Date:  1980-07       Impact factor: 5.422

7.  Establishment and characterization of a human histiocytic lymphoma cell line (U-937).

Authors:  C Sundström; K Nilsson
Journal:  Int J Cancer       Date:  1976-05-15       Impact factor: 7.396

8.  Abnormal bactericidal, metabolic, and lysosomal functions of Chediak-Higashi Syndrome leukocytes.

Authors:  R K Root; A S Rosenthal; D J Balestra
Journal:  J Clin Invest       Date:  1972-03       Impact factor: 14.808

9.  Induction of specific changes in the surface membrane of myeloid leukemic cells by steroid hormones.

Authors:  J Lotem; L Sachs
Journal:  Int J Cancer       Date:  1975-05-15       Impact factor: 7.396

10.  Amiloride inhibits murine erythroleukemia cell differentiation: evidence for a Ca2+ requirement for commitment.

Authors:  R Levenson; D Housman; L Cantley
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

View more
  29 in total

1.  Effects of 1 alpha,25-dihydroxyvitamin D3 and cytokines on the expression of MHC antigens, complement receptors and other antigens on human blood monocytes and U937 cells: role in cell differentiation, activation and phagocytosis.

Authors:  A Spittler; M Willheim; F Leutmezer; R Ohler; W Krugluger; C Reissner; T Lucas; T Brodowicz; E Roth; G Boltz-Nitulescu
Journal:  Immunology       Date:  1997-02       Impact factor: 7.397

2.  Induction of matrix Gla protein synthesis during prolonged 1,25-dihydroxyvitamin D3 treatment of osteosarcoma cells.

Authors:  J D Fraser; P A Price
Journal:  Calcif Tissue Int       Date:  1990-04       Impact factor: 4.333

Review 3.  Regulation of macrophage phagocytosis.

Authors:  D L Coleman
Journal:  Eur J Clin Microbiol       Date:  1986-02       Impact factor: 3.267

4.  Comparison of the mechanisms of bone resorption induced by 1 alpha,25-dihydroxyvitamin D3 and lipopolysaccharides.

Authors:  Y Shiina; A Yamaguchi; H Yamana; E Abe; S Yoshiki; T Suda
Journal:  Calcif Tissue Int       Date:  1986-07       Impact factor: 4.333

5.  Phagocytic cells synthesize 19-nor-10-keto-25-hydroxyvitamin D3, a metabolite that may induce differentiation of the human monoblastic cell line U937.

Authors:  T K Gray; D S Millington; D A Maltby; M E Williams; M S Cohen; R C Dodd
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

6.  Induction of (2'-5') oligoadenylate synthetase activity during granulocyte and monocyte differentiation.

Authors:  D Ferbus; U Testa; M Titeux; F Louache; M N Thang
Journal:  Mol Cell Biochem       Date:  1985-07       Impact factor: 3.396

Review 7.  Vitamin D, phagocyte differentiation and immune function.

Authors:  T K Gray; M S Cohen
Journal:  Surv Immunol Res       Date:  1985

8.  Establishment of a macrophagelike cell line derived from U-937, human histiocytic lymphoma, grown serum-free.

Authors:  Z L Kong; M Miwa; H Murakami; K Shinohara
Journal:  In Vitro Cell Dev Biol       Date:  1990-10

9.  The retinoic acid analog CBS-211A potentiates the 1 alpha,25-dihydroxyvitamin D3-induced differentiation of U937 cells.

Authors:  M Taimi; H Defacque; T Commes; J Favero; J Dornand; J Marti
Journal:  Agents Actions       Date:  1993-01

10.  Phagocytic cells metabolize 25-hydroxyvitamin D3 in vitro.

Authors:  M S Cohen; T K Gray
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.